Search

Displaying results 4111 - 4120 of 10000 in total
  1. Drug

    AR-9281

    go.drugbank.com/drugs/DB06345
    Investigational

    AR-9281 inhibits soluble epoxide hydrolase.

  2. Drug

    Cyclomethicone

    go.drugbank.com/drugs/DB14124
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Triglyme

    go.drugbank.com/drugs/DB02078
    Experimental

    Triethylene glycol dimethyl ether (also called triglyme) is a glycol ether used as a solvent.

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Triethylene glycol

    go.drugbank.com/drugs/DB02327
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Trimethyltetradecylammonium

    go.drugbank.com/drugs/DB17342
    Experimental

    Synonyms: 1-tetradecanaminium, n,n,n-trimethyl-Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Aminoethyl nitrate

    go.drugbank.com/drugs/DB13585
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  7. Drug

    3,4-Dihydroxycinnamic Acid

    go.drugbank.com/drugs/DB01880
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Ligelizumab

    go.drugbank.com/drugs/DB11856
    Investigational

    Ligelizumab is a humanized IgG1k monoclonal antibody targeted against immunoglobulin E (IgE). … a greater affinity for free serum IgE and an altered sensitivity to IgE conformation.

  9. Drug

    Platelet Lysate

    go.drugbank.com/drugs/DB15869
    Investigational

    Because white cell antigens are low in prepared lysate, there is a minimized likelihood of immune responses. … Platelet lysate is an acellular compound composed of platelet proteins while also being void of cellular debris, thus making the lysate rich with growth factors.

  10. Drug

    Rabeximod

    go.drugbank.com/drugs/DB05772
    Investigational

    Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.